Hemopure Addresses the Serious Threat Posed to Blood Supplies by the Emerging Infectious Diseases

While blood transfusion will always be the gold standard of treatment, there is an obvious need for alternative products, such as Hemopure, in the US healthcare system and emergency preparedness.

SOUDERTON, PA - March 26, 2020 /MarketersMedia/ —

Ensuring a regular and quality blood supply is a constant challenge for healthcare systems worldwide. In the US, according to data from the American Red Cross, a mere 3% of citizens normally donate blood even though 38% of the population are eligible to donate; Every two seconds, someone requires a transfusion; And a single donation could save as many as three lives. The current US blood supplies can barely meet the needs of patients, many of whom rely on transfusions to survive, either because of severe trauma, life-threatening medical conditions, or surgical complications. In times of national emergencies, such as pandemics or major natural disasters, the lack of sufficient supplies can lead to unnecessary loss of life, exacerbating already tragic situations. Hence, the strong advocacy from the medical and scientific communities for the development and use of blood substitutes, such as the oxygen-carrying solution Hemopure, manufactured by Hemoglobin Oxygen Therapeutics, a clinical-stage biotech company headquartered in Souderton, PA.

While clinicians have been able to use evidence-based medical and surgical concepts to optimize hemostasis and minimize blood loss in an effort to improve patient outcomes, the number of donors over the past few years has dropped significantly, more than negating any savings. An additional risk, this time to the safety of US blood supply, is that despite what officials describe as near-Herculean efforts to screen donated blood for the emerging viruses, the nation's blood supply is not immune from contaminations as was the case a few years ago when the CDC announced that several cases of West Nile illness were attributed to blood transfusions that contained tainted blood.

The push to develop alternatives to traditional blood transfusions has intensified in the 21st century amidst the global population growth and aging, the emergence of new infectious agents, and the seemingly rising number of natural disasters due to climate change. Not only is the number of donors insufficient to meet demand, but the nature of blood is such that it cannot be readily stockpiled, as refrigerated blood has a shelf-life of only 42 days. With multiple positive medical journal articles already published on Hemopure, its characteristics - including no blood typing or cross matching as well as three-year stability without the need for refrigeration - are ideal for out-of-hospital applications and stockpiling for national emergencies. It is no surprise then that the US Department of Defense is funding a large prehospital clinical trial to evaluate use of Hemopure as a resuscitation fluid in conjunction with freeze-dried plasma.

Currently, Hemopure is stocked and used at several hospitals as an investigational product, under FDA’s authorized expanded access protocols, for the treatment of severe anemia when blood transfusions are not an option. Interestingly, regulatory authorities in South Africa and Russia have already granted market approval for Hemopure for the treatment of perioperative anemia. “While blood transfusion will always be the gold standard of treatment, there is also an obvious need for alternative products, such as Hemopure, in our healthcare system and emergency preparedness,” experts at BloodSupplySolution.com assert. “Stakeholders in government, academic medicine and industry should find a way to work together to make this happen proactively rather than reactively.”

Blood Supply Solution – Oxygen-Carrying Blood Substitutes: http://bloodsupplysolution.com

Expanded Access Protocol Using HBOC-201 – ClinicalTrials.gov: https://clinicaltrials.gov/ct2/show/NCT02684474

Contact Info:
Name: Gail Weiss
Email: Send Email
Organization: BloodSupplySolution.com
Phone: 267-871-9577
Website: http://bloodsupplysolution.com

Source URL: https://marketersmedia.com/hemopure-addresses-the-serious-threat-posed-to-blood-supplies-by-the-emerging-infectious-diseases/88951297

Source: MarketersMedia

Release ID: 88951297

Recent News

Threat to US elections not limited to Russia in 2020

Apr 4, 2020

WASHINGTON — Russia interfered in the 2016 election and may try to sway next year's vote as well. But it's not the only nation with an eye on U.S. politics. American officials sounding the alarm about foreign efforts to disrupt the 2020 election include multiple countries in that warning. Concerns abound not only about possible hacking of campaigns, but also about the spread of disinformation on social media and potential efforts to breach voting databases and even alter votes. The anxiety goes beyond the possibility that U.S. adversaries could directly affect election results: The mere hint of foreign meddling could...

3 get Nobel prize for showing how cells sense low oxygen

Apr 4, 2020

NEW YORK — Two Americans and a British scientist won a Nobel Prize on Monday for discovering details of how the body's cells sense and react to low oxygen levels, providing a foothold for developing new treatments for anemia, cancer and other diseases. Drs. William G. Kaelin Jr. of Harvard University, Gregg L. Semenza of Johns Hopkins University and Peter J. Ratcliffe at the Francis Crick Institute in Britain and Oxford University won the prize for advances in physiology or medicine. The scientists, who worked largely independently, will share the 9 million kronor ($918,000) cash award, said the Karolinska Institute...

Where have the wild birds gone? 3 billion fewer than 1970

Apr 4, 2020

WASHINGTON — A comprehensive study shows there are nearly 3 billion fewer wild birds in North America than in 1970. The new study finds that the bird population in the United States and Canada was probably around 10.1 billion nearly half a century ago and has dropped 29% to about 7.2 billion birds. Study lead author Kenneth Rosenberg, a Cornell University conservation scientist, says the thinning of the flocks is happening before our eyes but is so slow we don't often notice. Rosenberg and colleagues projected population data using weather radar, which captures flocks of migrating birds, 13 different bird...

No Deal: Auto workers strike against GM in contract dispute

Apr 4, 2020

DETROIT — More than 49,000 members of the United Auto Workers walked off General Motors factory floors or set up picket lines early Monday as contract talks with the company deteriorated into a strike. Workers shut down 33 manufacturing plants in nine states across the U.S., as well as 22 parts distribution warehouses. It wasn't clear how long the walkout would last, with the union saying GM has budged little in months of talks while GM said it made substantial offers including higher wages and factory investments. It's the first national strike by the union since a two-day walkout in...

Union votes to strike at General Motors' US plants

Apr 4, 2020

DETROIT — The United Auto Workers union announced Sunday that its roughly 49,000 workers at General Motors plants in the U.S. would go on strike just before midnight because contentious talks on a new contract had broken down. About 200 plant-level union leaders voted unanimously in favor of a walkout during a meeting Sunday morning in Detroit. Union leaders said the sides were still far apart on several major issues and they apparently weren't swayed by a GM offer to make new products at or near two of the four plants it had been planning to close, according to someone...

About Us

Science Buzz is a user-friendly website which concentrates on news for the Big Three: Biology, Chemistry, and Physics.

Contact us: sales@thescnbuzz.com